ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,665,000 | +41525.0% | 910,000 | +45196.2% | 0.00% | – |
| Q1 2021 | $4,000 | -81.8% | 2,009 | -80.6% | 0.00% | – |
| Q4 2020 | $22,000 | +214.3% | 10,338 | +270.5% | 0.00% | – |
| Q3 2020 | $7,000 | -98.5% | 2,790 | -98.2% | 0.00% | – |
| Q2 2020 | $455,000 | +18.8% | 158,821 | +7.5% | 0.00% | – |
| Q1 2020 | $383,000 | -33.5% | 147,803 | +2.5% | 0.00% | – |
| Q4 2019 | $576,000 | +2780.0% | 144,137 | +3164.7% | 0.00% | – |
| Q3 2019 | $20,000 | +122.2% | 4,415 | +89.5% | 0.00% | – |
| Q2 2019 | $9,000 | – | 2,330 | +19316.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 12 | -95.7% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 279 | +108.2% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 134 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |